Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. 더 보기
WAYNE, Pa. and ROCKVILLE, Md., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.82 | 9.21348314607 | 8.9 | 9.63 | 8.3401 | 12090 | 9.22329128 | CS |
4 | 1.07 | 12.3699421965 | 8.65 | 11.87 | 6.84 | 31097 | 9.04956645 | CS |
12 | -3.28 | -25.2307692308 | 13 | 13.3 | 6.84 | 16674 | 9.89101672 | CS |
26 | 5.37 | 123.448275862 | 4.35 | 34.46 | 4.35 | 339664 | 19.20089938 | CS |
52 | -18.36 | -65.3846153846 | 28.08 | 52.752 | 3.9501 | 16679045 | 28.99869706 | CS |
156 | -575.88 | -98.3401639344 | 585.6 | 1711.2 | 3.9501 | 7951861 | 38.06868477 | CS |
260 | -679.08 | -98.5888501742 | 688.8 | 1711.2 | 3.9501 | 7803386 | 39.30941173 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관